KCNG4 encodes Kv6.4, a so-called electrically silent voltage-gated potassium channel subunit that cannot form a functional channel alone but reshapes channel behavior when co-assembled with Kv2 family pore-forming subunits such as KCNB1 and KCNB2.[1][2] In neurons, this modulatory role can shift activation/inactivation properties and therefore tune spike timing, repetitive firing, and network excitability.[2:1][3]
KCNG4 belongs to the Kv6 branch of modulatory subunits (Kv6.1-Kv6.4). These proteins are best understood as excitability set-point regulators rather than principal conductance carriers. By changing how Kv2-containing channels respond to depolarization, KCNG4 can alter the threshold and temporal structure of neuronal firing that feeds into vulnerability-relevant pathways in Alzheimer's disease, Parkinson's disease, and related disorders where membrane excitability, calcium stress, and synaptic failure interact.[2:2][4]
| Property | Value |
|---|---|
| Gene symbol | KCNG4 |
| Protein | Kv6.4 (voltage-gated potassium channel modifier subunit) |
| Chromosomal location | 16q24.1 |
| NCBI Gene | 3862 |
| Ensembl | ENSG00000168453 |
| UniProt | Q9Y698 |
Kv6.4 does not efficiently traffic to the surface as a homomer and does not generate a canonical delayed-rectifier current by itself.[1:1][2:3] Its biologic role emerges after heteromerization with Kv2 alpha subunits, where it can shift voltage dependence and inactivation kinetics.[1:2][2:4]
Excitability homeostasis is a central determinant of neuronal energy demand and calcium entry. Small shifts in repolarization reserve can modify burst probability and firing persistence, which then couples to mitochondrial workload, oxidative stress signaling, and proteostasis pressure linked to selective neuronal vulnerability.[3:1][4:1]
Transcriptomic and catalog resources indicate brain expression, with enrichment patterns varying by region and developmental context.[5][6] KCNG4 should be interpreted as a modifier node in a broader conductance network that includes voltage-gated sodium channels, Kv2 channels, and calcium channels.
In practical wiki terms, KCNG4 is most useful when cross-modeled with:
Human studies suggest KCNG4 variation can influence excitability-linked phenotypes. Reported associations include variant-level links to altered pain excitability phenotypes, supporting the concept that KCNG4 has measurable physiologic impact in humans.[7] More recent human genetics work has also explored associations between potassium-channel network variation and neurologic phenotypes, including headache spectrum traits.[8]
Direct causative links between KCNG4 and major neurodegenerative syndromes remain limited, but the mechanistic rationale is strong: KCNG4 modulates electrophysiologic programs that influence calcium loading and activity-dependent stress, which are shared drivers across Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and frontotemporal dementia.[3:2][4:2]
The study of Kcng4 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Ottschytsch N, Raes A, Timmermans JP, Snyders DJ. Domain analysis of Kv6.4, a silent Kv subunit. Journal of Physiology. 2002. ↩︎ ↩︎ ↩︎
Bocksteins E. Kv5, Kv6, Kv8, and Kv9 subunits: no simple silent bystanders. Journal of Physiology. 2016. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Martens JR, O'Connell K, Tamkun M. Targeting of ion channels in neurons. Physiology. 2014. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Surmeier DJ, Obeso JA, Halliday GM. Selective neuronal vulnerability in Parkinson disease. Nature Reviews Neuroscience. 2017. ↩︎ ↩︎ ↩︎ ↩︎
NCBI Gene. KCNG4 gene record. NCBI. 2026. ↩︎
UniProt Consortium. KCNG4 human protein entry Q9Y698. UniProt. 2026. ↩︎
Lee Y, et al. Human KCNG4 variant and labor pain phenotype. Cell Reports. 2020. ↩︎ ↩︎
Recio-Poveda L, et al. Potassium channel gene variants in migraine phenotypes. Human Genetics and Genomics Advances. 2024. ↩︎ ↩︎